-
March 11, 2016 •
News •
Jasmina •
Comments (0)
Global biopharmaceutical company Pfizer has announced the final stage of its $21 million Adelaide facility upgrade that will allow for the commercialisation of the cancer medicine pegfilgrastim. Health Industries Minister Jack Snelling said the facility will
-
April 4, 2014 •
News •
Jasmina •
Comments (0)
The first round of a new pilot funding program opened this week in Queensland, with at least $2 million available for biopharmaceutical product developers that want to make use of BioPharmaceuticals Australia’s (BPA) new Brisbane-based mammalian cell
